Introduction
Based on animal studies, it is accepted that a radiation exposure during the pre-implantation stage, before 4 weeks of gestation (i.e. weeks from the first day of last menstrual periods), leads to an « all or none » phenomena. Given the omnipotential nature of embryonic cells, the effects of radiation exposure may lead either to a miscarriage or no consequences [6] [7] [8] . The period between 4 and 10 weeks of gestation is extremely sensitive to the teratogenic effect of ionizing radiations and several cases of microcephaly, cataract and microphtalmia have been reported [9] [10] [11] [12] . From 10 weeks of gestation, the main reported risks of an exposure to ionizing radiations seems to be fetal growth restriction and mental retardation [13, 14] . However, most of these results are based on the prenatal exposure to much higher doses than those delivered in case of diagnostic irradiant examinations.
The objective of our study was to compare pregnancy outcomes in women with and without first trimester exposure to diagnostic sub diaphragmatic ionizing radiations.
Materials and Mmethods
We conducted a cohort study using data prospectively collected by our National Teratology Information Service between January 1stst, 1987 and December 31stst, 2014. The database used for the purpose of this study was authorized by the French Commission Nationale de l'Informatique et des Libertés (CNIL).
The exposed group consisted of pregnant women exposed to sub diaphragmatic irradiant examinations for diagnostic purposes between 2 and 15 weeks of gestation. The irradiant examinations included abdomen X-ray, lumbar spine X-ray and pelvis X-ray examinations, hysterosalpingography, intravenous urogram, abdomen and pelvis computerized tomography scan (CT scan), lumbar spine CT scan, cholangiography and abdominal scopic examinations.
The control group consisted of pregnant women without irradiant exposure during the pregnancy. These cases consisted of pregnant women for whom physicians called the National Teratology Information Service to report exposures with no known teratogenic risk (e.g. acetaminophen, penicillin, oral contraceptive stopped before 6 weeks, non-live vaccines, topical preparations with negligible systemic absorption, cosmetics) between 2 and 15 weeks of gestation. Unexposed patients were matched to the exposed ones for the calendar month of the first call to the center.
The exclusion criteria for both groups were an occupational exposure to ionizing radiations, radiotherapy or a concomitant use of a teratogenic drug (e.g. carbamazepine, carbimazole, cyclophosphamide, lithium, methotrexate, misoprostol, mycophenolate, phenobarbital, retinoids, thalidomide, valproic acid and vitamin K antagonists).
Data collection was performed using structured questionnaires at the first phone contact with the patient's physician, and after birth, sending questionnaires to the same physician. In all cases, data were recorded prospectively with no knowledge about the outcome of the pregnancy at the time of the first call. Recorded data were: maternal demographic characteristics, personal and familial medical history, current and previous obstetrical history, smoking, alcohol consumption and prescription and non-prescription drugs use.
Details about radiation exposures included the type of examination, its indication and the gestational age at exposure. The fetal dose exposure was recorded when the data was available, or was estimated according to the International Commission on Radiological Protection publication number 84 [16] . Prospective follow-up was conducted within two months after the expected date of delivery with emphasis on pregnancy complications, gestational age at delivery, birth weight, congenital malformations and neonatal complications.
An induced abortion before 14 weeks for personal reasons was defined as a voluntary termination of pregnancy, and a termination of pregnancy for a medical reason was defined as an elective termination of pregnancy.
The primary outcome of interest was the risk of major malformations after ionizing radiation exposure during the first trimester of pregnancy. Minor malformations were also recorded. Congenital malformations were classified as either major or minor in accordance with to the European Surveillance of Congenital Anomalies (EUROCAT) guide [17] . The secondary outcomes were the risk of miscarriage (spontaneous abortion before 22 weeks of gestation), stillbirth (intrauterine fetal death after 22 weeks of gestation) and fetal growth restriction defined as a birthweight lower than the 5thth percentile, due to this exposure.
Statistics
Continuous end points were expressed as means ± standard deviations (SD) and compared using the Student's t test.t-test Categorical end points were expressed as rates and compared between these groups using the chi-square test, or Fisher's exact test when the assumptions for the chi-square test were not met. A P-value less than 0.05 was considered significant. Statistical analyses were performed using R 3.3.2 Statistical Software.
Results
During the 28 years of the study, the National Teratology Information Service received 319 calls from physicians for a sub-diaphragmatic exposure to ionizing radiations during the first trimester of pregnancy. The pregnancy outcome of these 319 exposed women was compared with those of the 319 women of the control group. The two groups did not differ for maternal characteristics and for their initial risk of fetal malformations (familial history of congenital malformation, smoking, alcohol) ( Table 1) . The characteristics of ionizing radiations exposures are summarized in Table 2 . The irradiant examinations were performed at a mean gestational age of 4.5 weeks (minimum: 3.4, maximum: 5.3) and the women did not know about their condition of pregnancy in all cases. Among the 319 women of the radiations group, 194 (60.8%) were exposed to two examinations or more, on the same day. Most of the patients who had abdominal CT scan or lumbar spine CT scan, had first an abdomen X-ray or a lumbar spine X-ray examination. The median calculated dose received by the fetus was 3.1 mGy with a minimum of 0.2 mGy and a maximum of 130 mGy. All fetuses received a dose below 200 mGy, with a dose lower than 50 mGy for 311 fetuses (97.5%), and lower than 100 mGy for 317/319 fetuses (99.4%). For 66 patients from the radiations group (20.7%), we recorded a concomitant medication exposure, represented by analgesics and antibiotics prescription but with no associated risk for fetal anomaly or teratogenicity. Pregnancy outcomes in both groups are presented in Table 3 . No significant differences were observed for the rate of miscarriage before 22 weeks and intrauterine fetal death after 22 weeks. In the radiations group, the rate of voluntary termination of pregnancy was significantly higher than in the control group (7.8% and 3.1%, p = 0.02). No elective termination of pregnancy was recorded in the control group whereas 7 (2.2%) were performed in the radiations group. The overall live birth rate was significantly lower in the radiations group (81.8% vs 89.0%, p = 0.01). Among the two cases exposed to an irradiation dose higher than 100 mGy, there was one case of voluntary termination of pregnancy. The other pregnancy was continued and no anomalies were observed after at birth in the neonate. Indications for elective termination of pregnancy were chromosomal aberrations (Down syndrom: n = 2, trisomy 13: n = 2; trisomy 18: n = 1) and maternal conditions (psychiatric disorder: n = 1, severe ulcerative colitis: n = 1). Among the women who had elective termination of pregnancy for chromosomal anomalies, the median age was 33 ± 2 years old. Their irradiation exposures were represented by a pelvis X-ray and a lumbar spine X-ray at 5 weeks (Down syndrome, n = 1, and trisomy 13, n = 1), a pelvis X-ray alone at 4 weeks (Down syndrome, n = 1), an intravenous urogram at 5 weeks (trisomy 13, n = 1) and a hysterosalpingography at 3 weeks and 4 days (trisomy 18, n = 1). The elective termination of pregnancy were performed at a mean term of 16 +4 weeks with a mean delay of 12 weeks between the exposure and the elective termination of pregnancy.
Exposure to ionizing radiations was not associated with a lower birth weight, and there were no differences between the groups regarding the rate of fetal growth restriction. In both groups, no major malformations were observed. In the radiation group, among 261 newborns, we recorded 4 cases (1.5%) of minor malformations (two cases with moderate hydronephrosis, one angioma, one gastroesophageal reflux). In the control group, among 284 newborns, 5 cases (1.8%) of minor malformations were observed (one moderate hydronephrosis, one unilateral foot malposition, one cervical cyst, one gastroesophageal reflux, one ectopic kidney). In the radiation group, additionally to the 5 chromosomal aberrations resulting in an elective termination of pregnancy, one newborn presented a tetralogy of Fallot associated with a 22q1.1 deletion. The chromosomal anomaly rate was significantly higher in the exposed group with no cases in the control group (p = 0.03).
Discussion
This observational prospective cohort study indicates that exposure to diagnostic subdiaphragmatic ionizing radiations during the first trimester of pregnancy is not associated with an increased risk of major malformations, miscarriages, intrauterine fetal deaths or fetal growth restrictions.
Experimental studies with rodents and observation of nuclear accidents' victims found no increased risk of miscarriages with radiation doses under 200 mGy [7] , a threshold dose of 100 mGy for teratogenic effects [9, 18] and of 250 mGy for fetal growth restriction [18] . Osei et al. reported an observational study on the deterministic effects of prenatal radiation exposure for maternal diagnosis purpose, on a total of 50 pregnancies [19] . In this study, fetuses could be exposed at any time of the pregnancy, including second trimester, and the radiations exposures did not focus on the sub diaphragmatic area only. Furthermore, no comparison was made with a control group. In spite of these limitations, they concluded that prenatal radiation exposure in case of mother diagnostic examinations did not result in any deterministic effects. Our controlled study confirmed that prenatal exposure to sub diaphragmatic radiations with doses lower than 50 mGy does not increase the risk of congenital malformation, miscarriage, fetal growth restriction and intrauterine fetal death.
Our results are consistent with the recent systematic review of Gomes et al. and provide additional clinical arguments to support patients reassurance [20] .
In our study, we observed a relatively higher rate of voluntary termination of pregnancy in the exposed group. It is tempting to speculate that this higher rate of voluntary termination of pregnancy may reflect maternal anxiety caused by irradiation during pregnancy. We believe our results should make physicians more comfortable in their prenatal counselling to alleviate the maternal anxiety in case of prenatal exposition to diagnostic subdiaphragmatic ionizing radiations during the first trimester. Elective termination of pregnancy's rate was also significantly higher in the radiation group, but directly related to the chromosomal aberrations presented in this group. This high rate of chromosomal aberrations is difficult to explain, except as a selection bias.
This study included 319 women exposed to diagnosis ionizing radiations during early pregnancy, and is, to our knowledge, the only continuous prospective study with a control group to focus on the deterministic effects of ionizing radiations exposure during the first trimester of pregnancy. Moreover, we only focused on radiations exposure related to diagnosis purposes, which are minor exposures and are the most relevant for an analysis of factual clinical cases. Lastly, sub diaphragmatic radiations exposure during pregnancy represents the worst-case scenario because the fetus is located within the ionizing radiation field. If this kind of radiation is safe for the fetus, we can speculate that irradiation of other parts of the pregnant woman's body should be safer than sub diaphragmatic ones.
This study presents some limitations. We did not observe any major malformation in the two groups, nor the usual baseline prevalence of 1--3% of congenital birth defect, which could be explained by the size of this cohort. All cases were managed at national level, by the National Teratology Information Service, in direct collaboration with clinical physicians, and we have no reason to believe that there was a selection bias in any of our two groups. Also, although the patients of the control group have not been exposed to radiations during their pregnancy, their selection from the National Teratology Information Service database necessarily implies a drug exposure during their pregnancy (non-teratogenic drug). Unfortunately, we were not able to find a more suitable cohort due to the very long period of time on which this study is based. However, as many pregnant women are on medication during their pregnancy, we considered that this control group was consistent with reality [21] . Lastly, because children follow-up does not exceed two months, we are not able to provide data about mental retardation risk or carcinogenic risk. In this setting, the effect of prenatal exposure to low doses could not be studied.
In conclusion, prenatal exposure to diagnostic irradiant examination during the first trimester does not increase the risk of major or minor malformations, miscarriage, fetal death and fetal growth restriction. Therefore, appropriate counselling to women inadvertently exposed to radiations at early stages of pregnancy should be reassuring. Moreover, this kind of exposure should not be an indication for an elective termination of pregnancy, even if the radiological examination focuses on the pelvis. Overall, a relevant diagnostic procedure necessary for a woman's health should not be contraindicated in case of pregnancy. However, non-irradiant diagnosis procedures (ultrasound or magnetic resonance imaging) should be preferred in case of pregnancy [15] . Consequently, the diagnosis of pregnancy should be excluded in all women of childbearing age, before any irradiant procedure.
